FDA Approves Abbott’s “Low Dose,” Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life

By rw-admin | October 1, 2019 | Comments Off on FDA Approves Abbott’s “Low Dose,” Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life
Proclaim-XR

Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company’s Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform offers a low dose of Abbott’s proprietary BurstDR™ stimulation waveform, which was created based on scientific insights from doctors and research to mimic natural patterns found in…

Read More

Neocis Announces FDA 510(k) Clearance of Additional Drill for Use with Yomi® 

By rw-admin | October 1, 2019 | Comments Off on Neocis Announces FDA 510(k) Clearance of Additional Drill for Use with Yomi® 
Dr.-Benjamin-Kur_Robot-Assisted-Dental-Implantology-Dental-Implant-Surgery

Neocis, Inc., the leader and innovator in dental implant surgery using advanced robotics, today announced a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new dental drill for use with Yomi. This new clearance leads to an easier workflow and provides enhancements to the surgeons’ drilling experience. Yomi, the first and…

Read More